# US 2022/0267785 A1 · Optimized tissue-preferred promoter and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0267785 A1
- Document ID: US20220267785A1
- Status: Published application
- Kind: A1
- Application number: 17/684,078
- Filed: 2022-03-01
- Published: 2022-08-25
- Earliest claimed: 2018-08-02
- Assignees: Altria Client Services LLC
- Applicants: Altria Client Services LLC
- Inventors: Chengalrayan KUDITHIPUDI; Jaemo Yang; Yanxin Shen; Dongmei Xu; Ujwala Warek; James Strickland; Jesse Frederick
- Web page: https://patentgrep.com/patent/US20220267785A1

## CPC

- C12N 15/8229: {Meristem-specific, e.g. nodal, apical}
- C12N 15/8235: {Fruit-specific}
- C12N 15/8261: {with agronomic (input) traits, e.g. crop yield}
- C12N 15/827: {Flower development or morphology, e.g. flowering promoting factor [FPF]}
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present disclosure provides the identification of promoters that are preferentially active in tobacco axillary buds. Also provided are tobacco plants comprising reduced or no sucker growth. Also provided are methods and compositions for producing tobacco plants comprising reduced or no sucker growth.

## Claims

### Claim at position 1

-24. (canceled)

### Claim 25

Cured tobacco material comprising a DNA construct, wherein the DNA construct comprises a promoter comprising the nucleic acid sequence of SEQ ID NO: 257 operably linked to a heterologous nucleic acid molecule.

### Claim 26 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material is selected from the group consisting of air-cured tobacco material, fire-cured tobacco material, sun-cured tobacco material, and flue-cured tobacco material.

### Claim 27 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material is from a tobacco type selected from the group consisting of Burley tobacco, Maryland tobacco, bright tobacco, Virginia tobacco, Oriental tobacco, Turkish tobacco, and Galpão tobacco.

### Claim 28 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of CC 13, CC 27, CC 33, CC35, CC 37, CC 65, CC 67, CC 700, GF 318, GL 338, GL 368, GL 939, K 346, K 399, K326, NC 102, NC 196, NC 291, NC 297, NC 299, NC 471, NC 55, NC 606, NC 71, NC 72, NC 92, PVH 1118, PVH 1452, PVH 2110, SPEIGHT 168, SPEIGHT 220, SPEIGHT 225, SPEIGHT 227, and SPEIGHT 236.

### Claim 29 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Coker 48, Coker 176, Coker 371-Gold, Coker 319, Coker 347, GL 939, K 149, K326, K 340, K 346, K 358, K 394, K 399, K 730, NC 27NF, NC 37NF, NC 55, NC 60, NC 71, NC 72, NC 82, NC 95, NC 297, NC 606, NC 729, NC 2326, McNair 373, McNair 944, Ox 207, Ox 414 NF, Reams 126, Reams 713, Reams 744, RG 8, RG 11, RG 13, RG 17, RG 22, RG 81, RG H4, RG H51, Speight H-20, Speight G-28, Speight G-58, Speight G-70, Speight G-108, Speight G-111, Speight G-117, Speight 168, Speight 179, Speight NF-3, Va 116, and Va 182.

### Claim 30 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of K326, K346, and NC196.

### Claim 31 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Clay 402, Clay 403, Clay 502, Ky 14, Ky 907, Ky 910, Ky 8959, NC 2, NC 3, NC 4, NC 5, NC 2000, TN 86, TN 90, TN 97, R 610, R 630, R 711, R 712, NCBH 129, HB4488PLC, PD 7319LC, Bu 21×Ky 10, HB04P, Ky 14×L 8, Kt 200, Newton 98, Pedigo 561, Pf561 and Va 509.

### Claim 32 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of TN 90, KT 209, KT 206, KT212, and HB 4488.

### Claim 33 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Md 10, Md 40, Md 201, Md 609, Md 872 and Md 341.

### Claim 34 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Sumatra, Jatim, Dominican Cubano, Besuki, One sucker, Green River, Va. sun-cured, and Paraguan Passado.

### Claim 35 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Narrow Leaf Madole, Improved Madole, Tom Rosson Madole, Newton's VH Madole, Little Crittenden, Green Wood, Little Wood, Small Stalk Black Mammoth, DT 508, DT 518, DT 592, KY 171, DF 911, DF 485, TN D94, TN D950, VA 309, and VA 359.

### Claim 36 (depends on 25)

The cured tobacco material of claim 25, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Izmir, Katerini, Samsun, Basma and Krumovgrad, Trabzon, Thesalian, Tasova, Sinop, Izmit, Hendek, Edirne, Semdinli, Adiyanman, Yayladag, Iskenderun, Duzce, Macedonian, Mavra, Prilep, Bafra, Bursa, Bucak, Bitlis, and Balikesir.

### Claim 37 (depends on 25)

The cured tobacco material of claim 25, wherein said heterologous nucleic acid molecule encodes at least one axillary bud-degrading product.

### Claim 38 (depends on 37)

The cured tobacco material of claim 37, wherein said at least one axillary bud-degrading product is selected from the group consisting of a microRNA, a small interfering RNA, and a polypeptide.

### Claim 39 (depends on 38)

The cured tobacco material of claim 38, wherein said polypeptide comprises an amino acid sequence at least 70% identical or similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255.

### Claim 40 (depends on 38)

The cured tobacco material of claim 38, wherein said small RNA molecule comprises at least 18 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101.

### Claim 41 (depends on 1)

A bale of tobacco comprising the cured tobacco material of claim 1.

### Claim 42 (depends on 1)

The cured tobacco material of claim 1, wherein the cured tobacco material comprises cured tobacco leaves.

### Claim 43 (depends on 42)

The cured tobacco material of claim 42, wherein a tobacco product comprises the cured tobacco leaves.

### Claim 44 (depends on 43)

The cured tobacco material of claim 43, wherein the tobacco product is selected from the group consisting of a cigarette, a kretek, a bidi cigarette, a cigar, a cigarillo, a non-ventilated cigarette, a vented recess filter cigarette, pipe tobacco, snuff, chewing tobacco, moist smokeless tobacco, fine cut chewing tobacco, long cut chewing tobacco, and pouched chewing tobacco product.
